Pharmacia & Upjohn has confirmed that, at Volvo's request, it has filed a registration statement with the US Securities and Exchange Commission in relation to the divestment of shares in the company held by Volvo.
Volvo has a 13.7% stake in P&U, representing around 69.7 million shares. It is understood that the registration made by P&U at the SEC will allow Volvo to sell up to 52.9 million shares; around 66% of its total stake. In a Wall Street Journal report, analysts suggested that the market could not swallow the almost 14% stock divestment in one go. However, Volvo has made a commitment to severe its links with P&U by the end of the current year.
One analyst said that P&U must be happy to say goodbye to its major shareholder, as Volvo has already hurt the deal that management wanted. It will give the company more control over its own destiny.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze